Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Splendid IOM frenchbroad. Merci beaucoup.
Thanks LilKahuna, I miss your commentary on here. Hope all is well with you.
If I take Remdesivir plus Brilacidin and you take placebo plus SOC which is also Remdesivir and I live but you die which is better Brilacidin or Remdesivir?
Ipix on the move.
Pete could be right as more information becomes known from ongoing testing at government bio labs. Testing results that have already been released are extremely encouraging and unlike Kevetrin we are going to find out soon.
The boogie men of misinformation and nitpicking detraction immediately swung into action with long epistles of everything wrong with Leo. Street talk from street people in a street market.
An explosion of buying with little stock available. If there was an explosion of buying today the same would happen. The stock fell back on profit taking.
Shouldn’t have any affect.trading Ipix. Some others maybe, not Ipix.
Don’t believe it. Unreliable source.
IOM
Non-peptidic defensin-mimetic could be the answer to a lot of diseases. Brilacidin. Who’d a thought it!
IOM
The catalyst is staring you in the face Dunn. Brilacidin’s success.
IOM
I believe the potential of Brilacidin as witnessed by GMU and certain bio labs is by no means recognized in Ipix’ valuation. As we know science will win one way or perhaps another. Trash talking Leo is petty and a distraction which should be ignored. He is doing everything right to get Brilacidin approved.
IOM
If the conversation suddenly becomes about mimetics we could take off. IOM
Ipix on the move. IOM
The focus is Brilacidin anything else is absurd. IOM
Ipix on the move IOM
Ipix on the move LR that’s all that matters now. No need to write long epistles to only do Leo slamming at the end. We can expect more news from Alfasigma soon.
IOM
Yup they should go straight to market.
The ones out with the sharp knives are about to get them severely blunted. Ipix on the move (IOM]. Does one need the “t”?
Could they learn enough from the trial. 3 then 5 days etc., and can a double blinded trial be undone anyway?
I think you are a little ahead of yourself here but it’s great you see this going to market. Ipix on the move.
That’s funny I suppose it’s for your note book and nothing to do with the future success of Brilacidin. Ipix are on the move.
Excellent news PJ007 we’ll keep the dream police at bay.
There’s more to Ipix now as Alfasigma move forward with their trials. More exposure for Brilacidin with more to follow. 18 cents could easily be 50 plus with the tiniest sniff of good fortune and a lot more if right.
I am very glad that Leo reminded us that pill form Brilacidin is being formulated for Irritable bowel disease. Successfully targeting IBD would be massive if Ipix can do it. At 18 cents the pay off even without COVID 19 could be great. With it, then multiple dollars.
So with the IBD prospect of Brilacidin being a potential cure is Ipix really without backup? It may be a slow developer but I certainly wouldn’t discount it. I’d put it in the news pending category.
Agree it will be very interesting.
Strictly by the rules (for some) as the pandemic rages on around the world.
What a ridiculous argument considering the company was running on a shoe string when she arrived and still is until the science changes things.
It’s the final data not interim data that counts. Brilacidin has lost none of it’s potential and can still become a wonder drug either under Ipix’s ownership or somebody else’s.
And they are all doing great. You left that bit out.
The value of all the bio lab research is changing the outlook for Brilacidin. Reported at the time we first heard of their interest to test Brilacidin we were told how valuable they would be to us. It’s coming true.
I don’t think Ipix understood their own drug but luckily new research is coming to their rescue. All this greatly increases the value of Brilacidin.
Great post as real time research about Brilacidin gets more exciting every day. The sp will catch on soon.
His job is to keep shareholders informed and I for one fully appreciate it.
Dunn I believe you fail to understand that WE shareholders together with the rest of the world are discovering the incredible properties of Brilacidin together. And what we are learning is truly fantastic.
Wake up everybody!
I think saying one is on here for the mental exercise is deceitful but I can’t prove it.
More and more awareness that Brilacidin is a different class of drug and has the research behind it could set off a major rally in Ipix’s share price. Lot’s more eyeballs coming our way!
What an endorsement to the bio lab research that’s ongoing and hopefully will become part Ipix’s future.